226 related articles for article (PubMed ID: 33592124)
21. SMYD2 overexpression is associated with tumor cell proliferation and a worse outcome in human papillomavirus-unrelated nonmultiple head and neck carcinomas.
Ohtomo-Oda R; Komatsu S; Mori T; Sekine S; Hirajima S; Yoshimoto S; Kanai Y; Otsuji E; Ikeda E; Tsuda H
Hum Pathol; 2016 Mar; 49():145-55. PubMed ID: 26826421
[TBL] [Abstract][Full Text] [Related]
22. Non-HPV-Related Head and Neck Squamous Cell Carcinoma in a Young Patient Cohort.
Dougherty MI; Dougherty W; Kain JJ; Hughley BB; Shonka DC; Fedder KL; Jameson MJ
Ear Nose Throat J; 2021 Dec; 100(10_suppl):1101S-1106S. PubMed ID: 32584613
[TBL] [Abstract][Full Text] [Related]
23. An immune-related seven-lncRNA signature for head and neck squamous cell carcinoma.
Chen Y; Luo TQ; Xu SS; Chen CY; Sun Y; Lin L; Mao YP
Cancer Med; 2021 Apr; 10(7):2268-2285. PubMed ID: 33660378
[TBL] [Abstract][Full Text] [Related]
24. The prognosis of HPV-associated metastatic pharyngeal patients by primary and distant site.
Wang J; Tian Y; Huang H; Huang D; Liu Y; Tian Y; Zhu G; Zhang X; Ferris RL
Oral Oncol; 2022 Feb; 125():105675. PubMed ID: 34968864
[TBL] [Abstract][Full Text] [Related]
25. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
[TBL] [Abstract][Full Text] [Related]
26. Human papillomavirus (HPV) 16 and the prognosis of head and neck cancer in a geographical region with a low prevalence of HPV infection.
López RV; Levi JE; Eluf-Neto J; Koifman RJ; Koifman S; Curado MP; Michaluart-Junior P; Figueiredo DL; Saggioro FP; de Carvalho MB; Kowalski LP; Abrahão M; de Góis-Filho F; Tajara EH; Waterboer T; Boffetta P; Brennan P; Wünsch-Filho V
Cancer Causes Control; 2014 Apr; 25(4):461-71. PubMed ID: 24474236
[TBL] [Abstract][Full Text] [Related]
27. Peripheral blood monocyte and T-lymphocyte activation levels at diagnosis predict long-term survival in head and neck squamous cell carcinoma patients.
Aarstad HJ; Vintermyr OK; Ulvestad E; Aarstad HH; Kross KW; Heimdal JH
APMIS; 2015 Apr; 123(4):305-14. PubMed ID: 25801083
[TBL] [Abstract][Full Text] [Related]
28. Extracapsular extension of neck nodes and absence of human papillomavirus 16-DNA are predictors of impaired survival in p16-positive oropharyngeal squamous cell carcinoma.
Freitag J; Wald T; Kuhnt T; Gradistanac T; Kolb M; Dietz A; Wiegand S; Wichmann G
Cancer; 2020 Jan; 126(9):1856-1872. PubMed ID: 32032442
[TBL] [Abstract][Full Text] [Related]
29. Human papillomavirus infection on initiating synchronous esophageal neoplasia in patients with head and neck cancer.
Wang WL; Wang YC; Chang CY; Lo JL; Kuo YH; Hwang TZ; Wang CC; Mo LR; Lin JT; Lee CT
Laryngoscope; 2016 May; 126(5):1097-102. PubMed ID: 27107411
[TBL] [Abstract][Full Text] [Related]
30. NDN and CD1A are novel prognostic methylation markers in patients with head and neck squamous carcinomas.
Virani S; Bellile E; Bradford CR; Carey TE; Chepeha DB; Colacino JA; Helman JI; McHugh JB; Peterson LA; Sartor MA; Taylor JM; Walline HM; Wolf GT; Rozek LS
BMC Cancer; 2015 Oct; 15():825. PubMed ID: 26518708
[TBL] [Abstract][Full Text] [Related]
31. Prevalence and impact on clinicopathological characteristics of human papillomavirus-16 DNA in cervical lymph node metastases of head and neck squamous cell carcinoma.
Weiss D; Koopmann M; Rudack C
Head Neck; 2011 Jun; 33(6):856-62. PubMed ID: 20737490
[TBL] [Abstract][Full Text] [Related]
32. Imaging characteristics of metastatic nodes and outcomes by HPV status in head and neck cancers.
Fujita A; Buch K; Truong MT; Qureshi MM; Mercier G; Jalisi S; Sugimoto H; Sakai O
Laryngoscope; 2016 Feb; 126(2):392-8. PubMed ID: 26344563
[TBL] [Abstract][Full Text] [Related]
33. Transfer RNA methyltransferase gene NSUN2 mRNA expression modifies the effect of T cell activation score on patient survival in head and neck squamous carcinoma.
Lu L; Gaffney SG; Cannataro VL; Townsend J
Oral Oncol; 2020 Feb; 101():104554. PubMed ID: 31887619
[TBL] [Abstract][Full Text] [Related]
34. Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients.
Laban S; Gangkofner DS; Holzinger D; Schroeder L; Eichmüller SB; Zörnig I; Jäger D; Wichmann G; Dietz A; Broglie MA; Herold-Mende CC; Dyckhoff G; Boscolo-Rizzo P; Ezić J; Marienfeld R; Möller P; Kraus JM; Völkel G; Kestler HA; Brunner C; Schuler PJ; Wigand MC; Theodoraki MN; Doescher J; Hoffmann TK; Pawlita M; Waterboer T; Butt J
Clin Cancer Res; 2019 Dec; 25(24):7405-7412. PubMed ID: 31444248
[TBL] [Abstract][Full Text] [Related]
35. Head and neck squamous cell carcinoma in HIV, HBV and HCV seropositive patients - Prognosis and its predictors.
Nayyar SS; Thiagarajan S; Malik A; D'Cruz A; Chaukar D; Patil P; Alahari AD; Lashkar SG; Prabhash K
J Cancer Res Ther; 2020; 16(3):619-623. PubMed ID: 32719277
[TBL] [Abstract][Full Text] [Related]
36. Socioeconomic Status Drives Racial Disparities in HPV-negative Head and Neck Cancer Outcomes.
Lenze NR; Farquhar D; Sheth S; Zevallos JP; Blumberg J; Lumley C; Patel S; Hackman T; Weissler MC; Yarbrough WG; Zanation AM; Olshan AF
Laryngoscope; 2021 Jun; 131(6):1301-1309. PubMed ID: 33170518
[TBL] [Abstract][Full Text] [Related]
37. ERCC1 protein expression is associated with differential survival in oropharyngeal head and neck squamous cell carcinoma.
Patel MR; Zhao N; Ang MK; Stadler ME; Fritchie K; Weissler MC; Zanation AM; Harris SL; Funkhouser WK; Olshan AF; Shores CG; Hayes DN
Otolaryngol Head Neck Surg; 2013 Oct; 149(4):587-95. PubMed ID: 23846458
[TBL] [Abstract][Full Text] [Related]
38. Plasma cell marker, immunoglobulin J polypeptide, predicts early disease-specific mortality in HPV+ HNSCC.
Gui S; O'Neill WQ; Teknos TN; Pan Q
J Immunother Cancer; 2021 Mar; 9(3):. PubMed ID: 33737336
[TBL] [Abstract][Full Text] [Related]
39. FGFR1 Is a Potential Prognostic Biomarker and Therapeutic Target in Head and Neck Squamous Cell Carcinoma.
Koole K; Brunen D; van Kempen PM; Noorlag R; de Bree R; Lieftink C; van Es RJ; Bernards R; Willems SM
Clin Cancer Res; 2016 Aug; 22(15):3884-93. PubMed ID: 26936917
[TBL] [Abstract][Full Text] [Related]
40. High expression of GPNMB predicts poor prognosis in head and neck squamous cell carcinoma.
Li H; Xiao Y; Wu CC; Yang LL; Cao LY; Chen DR; Zhou JJ; Zhang WF; Sun ZJ
Histol Histopathol; 2019 Jul; 34(7):803-810. PubMed ID: 30632601
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
